JPMorgan lowered the firm’s price target on Healthcare Realty Trust (HR) to $17 from $18 and keeps a Neutral rating on the shares. The firm updated the company’s model.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HR:
- Healthcare Realty Trust Announces Board Restructuring
- Healthcare Realty Trust reduces size of board to seven members
- Healthcare Realty Trust Appoints New Director and CEO
- Healthcare Realty Trust Reports Q1 2025 Results
- Healthcare Realty Trust’s Mixed Earnings Call: Leasing Shines Amid Leverage Concerns